Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 28NIH 12INDUSTRY 12NETWORK 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Nasopharyngeal Carcinoma 5Lung Neoplasms 5Nasopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Neoplasms, Germ Cell and Embryonal 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Squamous Cell 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Cancer 1Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1

Interventions

liposomal doxorubicin 1Talc 1Cisplatin 1Cerebral Decortication 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Mesothelioma, Malignant × Cisplatin × Clear all
NCT00886028 2009-04-22

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

National Institute of Cancerología

Phase 2 Unknown
31 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡